Reinsurance Group of America (NYSE:RGA) Rating Lowered to Hold at StockNews.com

Reinsurance Group of America (NYSE:RGA) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Thursday.

A number of other brokerages also recently weighed in on RGA. UBS Group boosted their price target on Reinsurance Group of America from $223.00 to $240.00 and gave the company a “buy” rating in a report on Thursday, May 30th. Barclays began coverage on shares of Reinsurance Group of America in a research note on Wednesday. They set an “overweight” rating and a $255.00 target price for the company. Evercore ISI raised their price target on shares of Reinsurance Group of America from $225.00 to $241.00 and gave the stock an “outperform” rating in a research report on Wednesday, June 26th. Raymond James boosted their price objective on shares of Reinsurance Group of America from $212.00 to $228.00 and gave the company a “strong-buy” rating in a research report on Friday, June 14th. Finally, Wells Fargo & Company raised their target price on shares of Reinsurance Group of America from $236.00 to $239.00 and gave the stock an “overweight” rating in a report on Friday, August 9th. Three analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $223.33.

Reinsurance Group of America Stock Down 1.4 %

NYSE RGA traded down $3.15 during trading hours on Thursday, reaching $216.44. 225,593 shares of the company traded hands, compared to its average volume of 365,561. The stock has a market capitalization of $14.25 billion, a PE ratio of 16.82 and a beta of 0.91. The company has a current ratio of 0.17, a quick ratio of 0.17 and a debt-to-equity ratio of 0.52. Reinsurance Group of America has a 12 month low of $136.04 and a 12 month high of $227.87. The company has a 50 day moving average of $211.26 and a two-hundred day moving average of $200.07.

Reinsurance Group of America (NYSE:RGA) last issued its earnings results on Thursday, August 1st. The insurance provider reported $5.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.94 by $0.54. The business had revenue of $4.88 billion for the quarter, compared to analyst estimates of $5.07 billion. Reinsurance Group of America had a net margin of 4.01% and a return on equity of 15.84%. The company’s revenue for the quarter was up 17.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $4.40 EPS. As a group, equities analysts expect that Reinsurance Group of America will post 21.5 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in RGA. Pineridge Advisors LLC acquired a new stake in Reinsurance Group of America in the fourth quarter worth approximately $26,000. New Covenant Trust Company N.A. acquired a new stake in shares of Reinsurance Group of America in the first quarter valued at $28,000. International Assets Investment Management LLC bought a new position in Reinsurance Group of America during the second quarter valued at about $28,000. Rise Advisors LLC acquired a new position in Reinsurance Group of America during the first quarter worth about $29,000. Finally, Family Firm Inc. bought a new stake in Reinsurance Group of America in the second quarter worth about $29,000. 95.11% of the stock is currently owned by institutional investors.

Reinsurance Group of America Company Profile

Reinsurance Group of America, Incorporated engages in reinsurance business. The company offers individual and group life and health insurance products, such as term life, credit life, universal life, whole life, group life and health, joint and last survivor insurance, critical illness, disability, and longevity products; asset-intensive and financial reinsurance products; and other capital motivated solutions.